<p>(a)All study population: AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P = 0.05), AUC-model vs. AUC-tPSA(P>0.05); (b) Age≤60 yr, AUC-tPSA vs. AUC-%fPSA (P>0.05), AUC-PSAD vs. AUC-tPSA(P>0.05), AUC-model vs. AUC-tPSA(P>0.05); (c) Age 61–80 yr, AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P>0.05), AUC-model vs. AUC-tPSA(P>0.05); (d) Age≥81 yr, AUC-tPSA vs. AUC-%fPSA (P>0.05), AUC-PSAD vs. AUC-tPSA(P>0.05), AUC-model vs. AUC-tPSA(P>0.05).</p
Indication for prostate biopsy is presently mainly based on prostate-specific antigen (PSA) serum le...
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA dens...
This study is a head-to-head comparison between mPSAD and MRI-PMbdex. The MRI-PMbdex was created fro...
<p>(a)All study population: AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P>0.05), AUC-mod...
<p>(a)All study population: AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P<0.001), AUC-mo...
<p>ROC curves of %fPSA and PSA in predicting any prostate cancer for patients aged (A) 50–59 years; ...
casian men aged between 37 and 92 years underwent transperineal prostate biopsy for suspicion of PCa...
Background: Prostate cancer over-diagnosis and over treatment for indolent disease is an area of co...
<p>ROC curves of %fPSA and PSA in predicting high-grade prostate cancer for patients aged (A) 50–59 ...
Background: Prostate cancer over-diagnosis and over treatment for indolent disease is an area of co...
Background: A new prostate cancer (PCa) prognostic grading system [Gleason groups (GGs)] has been pr...
In this study, we aimed to validate the Prostate Health Index (PHI) for the detection of prostate ca...
Background: The aim of our study was to identify the optimal predictor of prostate cancer among seve...
OBJECTIVE: The objective of our study was to investigate the diagnostic performance of prebiopsy b...
Objectives:The primary objective of the study was to correlate the Prostate Specific Antigen Density...
Indication for prostate biopsy is presently mainly based on prostate-specific antigen (PSA) serum le...
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA dens...
This study is a head-to-head comparison between mPSAD and MRI-PMbdex. The MRI-PMbdex was created fro...
<p>(a)All study population: AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P>0.05), AUC-mod...
<p>(a)All study population: AUC-tPSA vs. AUC-%fPSA (P<0.001), AUC-PSAD vs. AUC-tPSA(P<0.001), AUC-mo...
<p>ROC curves of %fPSA and PSA in predicting any prostate cancer for patients aged (A) 50–59 years; ...
casian men aged between 37 and 92 years underwent transperineal prostate biopsy for suspicion of PCa...
Background: Prostate cancer over-diagnosis and over treatment for indolent disease is an area of co...
<p>ROC curves of %fPSA and PSA in predicting high-grade prostate cancer for patients aged (A) 50–59 ...
Background: Prostate cancer over-diagnosis and over treatment for indolent disease is an area of co...
Background: A new prostate cancer (PCa) prognostic grading system [Gleason groups (GGs)] has been pr...
In this study, we aimed to validate the Prostate Health Index (PHI) for the detection of prostate ca...
Background: The aim of our study was to identify the optimal predictor of prostate cancer among seve...
OBJECTIVE: The objective of our study was to investigate the diagnostic performance of prebiopsy b...
Objectives:The primary objective of the study was to correlate the Prostate Specific Antigen Density...
Indication for prostate biopsy is presently mainly based on prostate-specific antigen (PSA) serum le...
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA dens...
This study is a head-to-head comparison between mPSAD and MRI-PMbdex. The MRI-PMbdex was created fro...